ALSO NOTED: Alfacell shares surge; Galapagos signs collaboration pacts; and much more...

> Alfacell's shares surged 13 percent after researchers reported that onconose demonstrated promising results in a preclinical study. Report

> The service division of Belgium's Galapagos has signed two new collaboration pacts with Ono Pharmaceutical. The pacts call for BioFocus DPI to provide screening services and medical chemistry projects. Report

> Kosan Biosciences announced that its cancer drug tanespimycin passed a significant safety test. Report

> TomoTherapy has set the terms for its IPO, pricing 10.9 million shares at a range of $15 to $17. Report

> The FDA has approved GlaxoSmithKline's antibacterial Altabax for impetigo. Release

> Sirion Therapeutics has received the FDA's orphan drug designation for its anti-viral therapy, ganciclovir, for the treatment of acute herpetic keratitis. Release

> The FDA will give a priority review for GPC Biotech's chemotherapy satraplatin in combination with the steroid prednisone for hormone-refractory prostate cancer patients who have failed prior chemotherapies. Report

> Cytochroma and Genzyme have settled a lawsuit regarding alleged misappropriation of trade secrets. Release

And Finally… Cambodia has confirmed a new outbreak of bird flu just days after a 13-year-old girl died from the virus. Report